With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...
Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...
Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases. The ...
The special properties of methylcellulose foam could make it a vehicle for bedside genetic engineering, according to a proof-of-principle study from bioengineers at Fred Hutch Cancer Center. In the ...
Treatment with onasemnogene abeparvovec gene therapy for spinal muscular atrophy (SMA) type 1 was associated with less need for nutritional support or nighttime ventilation compared to recommended ...
She has a genetic condition that affects motor nerve cells in the spinal cord, causing progressive muscle weakness. Read more ...
The 23-year-old man received a gene therapy transfusion Wednesday at Manning Family Children's Hospital that doctors say ...
SAR446268 is a one-time adeno-associated viral gene therapy that delivers a vectorized RNA interference to silence DMPK expression. The Food and Drug Administration (FDA) has granted Fast Track ...
Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to restore natural hearing for those born with a rare form of deafness, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results